Home » Archive

News

News, Syndication, Xconomy »

SD Life Sciences Roundup: Accelrys, Illumina, & RainTree Oncology

Posted by sandiegobiotech April 19th, 2012 .
No Comments

There was a mix of news out of San Diego’s life sciences community over the past week. Get your briefing here. —San Diego’s Sotera Wireless said the FDA has cleared its ViSi Mobile System, a wireless…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

Illumina Stays Independent, Roche Walking Away

Posted by sandiegobiotech April 18th, 2012 .
No Comments

Illumina will remain an independent company, at least for now. The San Diego-based company (NASDAQ: ILMN), the market leading maker of DNA sequencing instruments, fended off a hostile takeover bid by…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Small is Beautiful in Q1 Venture Deals as VCs Write Lots of Checks

Posted by sandiegobiotech April 17th, 2012 .
No Comments

Venture investors wrote lots of checks during the first three months of 2012, but the amounts were small, according to the venture capital activity report being released today by CB Insights, the New…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

La Jolla Pharmaceutical Company Announces Development Programs for Lead Product, GCS-100

Posted by Mary Canady April 16th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 16, 2012) – La Jolla Pharmaceutical Company (OTCQB: LJPC) (PINKSHEETS: LJPC) today announced initial product development plans for advancing GCS-100, its first-in-class inhibitor of galectin-3.
On January 20, …

More...

News, Syndication, Xconomy »

Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1

Posted by sandiegobiotech April 16th, 2012 .
No Comments

Sometimes the biggest success stories in business never make it to the magazine covers. There’s no single Eureka moment, no surprise turning point, no redemption, no swashbuckling CEO delivering the…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

Quidel to Hold First Quarter 2012 Financial Results Conference Call on April 25, 2012

Posted by Mary Canady April 13th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 13, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release first quarter 2012 financial results after market close on Wedn…

More...

News, Syndication, Xconomy »

Tioga Investor Thomas McNerney Keeping Busy After San Diego Move

Posted by sandiegobiotech April 12th, 2012 .
No Comments

Thomas, McNerney & Partners, the life sciences investor that moved its West Coast office to San Diego last year, led the latest financing round in San Diego’s Tioga Pharmaceuticals, which I…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

SD Life Sciences Roundup: Optimer, Illumina, & Deals, Deals, Deals

Posted by sandiegobiotech April 12th, 2012 .
No Comments

In an encouraging sign for San Diego’s life sciences sector, a number of new financing deals recently went to local companies. Here’s our roundup of all the news. —Shareholder suits have begun to…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

BioPharma Needs A Safe, Reliable Way To Repair Broken Genes

Posted by sandiegobiotech April 11th, 2012 .
No Comments

The sequencing of the human genome didn’t immediately lead to treatments for a number of diseases, as many had hoped and a smaller number had predicted. However, the enormous drop in the price of DNA…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Cardinal Health Hires West Wireless Health Institute’s Inaugural CEO

Posted by sandiegobiotech April 11th, 2012 .
No Comments

It felt like an auspicious time when Don Casey arrived two years ago as the inaugural CEO for San Diego’s new West Wireless Health Institute. Founders Gary and Mary West, who made their fortune in…

[[Click headline to continue reading.]]

More...